Miss Amy Jo Winjum, OTR/L | |
150 County Rd 34, Arthur Good Samaritan Center, Arthur, ND 58006-4100 | |
(701) 967-8316 | |
(701) 967-8961 |
Full Name | Miss Amy Jo Winjum |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 150 County Rd 34, Arthur, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992992341 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 792 (North Dakota) | Primary |
225X00000X | Occupational Therapist | 103188 (Minnesota) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Miss Amy Jo Winjum, OTR/L 3585 Buchanan St S, Fargo, ND 58104-7508 Ph: (701) 388-4604 | Miss Amy Jo Winjum, OTR/L 150 County Rd 34, Arthur Good Samaritan Center, Arthur, ND 58006-4100 Ph: (701) 967-8316 |
News Archive
Same-sex couples that live together report worse health than people of the same socioeconomic status who are in heterosexual marriages, according to a national study that could have implications for the gay marriage debate.
The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the first anti-PD-1 immunotherapy in the United States for treatment of advanced and unresectable malignant melanoma.
In the January 18th issue of Molecular Cell, Case Western Reserve University School of Medicine researcher Kristian E. Baker, Ph.D. challenges molecular biology's established body of evidence and widely-accepted model for nonsense-mediated messenger ribonucleic acid (mRNA) decay.
Taiho Pharmaceutical Co., Ltd. announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the Japanese Society of Medical Oncology held in Yokohama.
For most people, wisdom teeth are not much more than an annoyance that eventually needs to be removed. However, a new study appearing in the September 17 Journal of Biological Chemistry shows that wisdom teeth contain a valuable reservoir of tissue for the creation of stem cells; thus, everyone might be carrying around his or her own personal stem-cell repository should he or she ever need some.
› Verified 4 days ago
Nicole Oster, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 County Road 34, Arthur, ND 58006 Phone: 701-710-0411 |